Body says AstraZeneca breached code over misleading claim National guidelines for asthma treatment were different AstraZeneca disputes safety risk but updates website after complaint Oct 24 (Reuters) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback